Summary
Lanreotide, a synthetic octapeptide analog of a native hormone somatostatin, was labeled with 131I, the most widely used therapeutic and easily available radionuclide. Radioiodination of Lanreotide was carried out by Chloramine-T and Iodogen methods. Chloramine-T and Iodogen were used as oxidizing agents to form an electrophilic iodine species, which then labeled the tyrosine of Lanreotide. The maximum radiolabeling yield was ~80%. Chloramine-T was found more suitable than the Iodogen method, because nearly 25% of the initial iodine activity was lost/adsorbed on the Iodogen coating. Thin layer and high performance liquid chromatographies were used for monitoring the reaction of 131I with Lanreotide, the stability and purity of 131I-Lanreotide.
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Pervez, S., Mushtaq, A. Preparation, quality control and stability of 131I-Lanreotide. J Radioanal Nucl Chem 266, 265–268 (2005). https://doi.org/10.1007/s10967-005-0902-7
Issue Date:
DOI: https://doi.org/10.1007/s10967-005-0902-7